CZ VACCINES

czvaccines.com

CZ Vaccines, before Known as CZ Veterinaria, is a worldwide leader in the application of advances in biotechnology to vaccine production and one of the foremost biotechnology companies in the European Union. CZ Vaccines has a strong presence across 60 countries. CZ Vaccines is a biopharmaceutical company that is dedicated exclusively to the development and manufacture of veterinary products and medicines. State-of-the-art technology, modern production systems and high-performance manufacturing plants that meet stringent quality standards are the foundation that guarantees the production of cutting edge products. CZ Vaccines has its own products that are distributed through third parties. In addition, it contract manufactures a comprehensive range of pharmaceutical and biological products for large multinational companies and governments around the world.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

WCG ANNOUNCES PARTNERSHIP WITH MINT MEDICAL TO SUPPORT IMAGING IN ONCOLOGY CLINICAL TRIALS

PRNewswire | June 29, 2023

news image

WCG, one of the world's leading providers of solutions that measurably improve the quality, efficiency, and safety of clinical research, recently announced a partnership with Mint Medical to leverage its mint Lesion™ radiology platform for oncology trials. The mint Lesion™ software is used for standardized and computer-assisted review of medical imaging according to defined protocols, guidelines, and workflows. Compliant and highly configurable, mint Lesion&trade...

Read More

Business Insights, PHARMACY MARKET

ENDO LAUNCHES AUTHORIZED GENERIC VERSION OF NOXAFIL® (POSACONAZOLE) ORAL SUSPENSION

Prnewswire | April 04, 2023

news image

Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized generic (AG) version of Merck's Noxafil® (posaconazole) 200 mg/5 mL oral suspension in the U.S. "Our partnership with Merck underscores our reputation as an industry-leading supplier," said Scott Sims, Senior Vice President and General Manager, Injectable Solutions & Generics at Endo. "This newly available Noxafil® AG do...

Read More

AMAZON INTENSIFIES PUSH INTO AUSTRALIAN PHARMACY WITH TRADEMARK APPLICATION

Smh | June 01, 2020

news image

Retail giant Amazon has intensified its push into Australia's highly competitive pharmaceuticals sector, brushing off industry opposition with a fresh trademark application for a range of private-label over-the-counter medications. Amazon filed the application for the 'BasicCare' trademark on Friday and refers to Amazon-branded medication which shoppers can buy directly from the e-commerce giant. The move comes as Amazon faces a fight with the Pharmacy Guild of Australia over a previ...

Read More

PHARMA TECH

FRONTAGE LABORATORIES ACQUIRES ACCELERA S.R.L.'S BIOANALYTICAL AND DMPK BUSINESSES

PR Newswire | January 03, 2024

news image

Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera). Accelera is a premier Contract Research Organization located in Nerviano, within the Lombardy region of Italy, part of the well-established NMS Group S.p.A. which has positioned itself as a global niche player in delivering discovery &...

Read More
news image

Pharma Tech

WCG ANNOUNCES PARTNERSHIP WITH MINT MEDICAL TO SUPPORT IMAGING IN ONCOLOGY CLINICAL TRIALS

PRNewswire | June 29, 2023

WCG, one of the world's leading providers of solutions that measurably improve the quality, efficiency, and safety of clinical research, recently announced a partnership with Mint Medical to leverage its mint Lesion™ radiology platform for oncology trials. The mint Lesion™ software is used for standardized and computer-assisted review of medical imaging according to defined protocols, guidelines, and workflows. Compliant and highly configurable, mint Lesion&trade...

Read More
news image

Business Insights, PHARMACY MARKET

ENDO LAUNCHES AUTHORIZED GENERIC VERSION OF NOXAFIL® (POSACONAZOLE) ORAL SUSPENSION

Prnewswire | April 04, 2023

Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized generic (AG) version of Merck's Noxafil® (posaconazole) 200 mg/5 mL oral suspension in the U.S. "Our partnership with Merck underscores our reputation as an industry-leading supplier," said Scott Sims, Senior Vice President and General Manager, Injectable Solutions & Generics at Endo. "This newly available Noxafil® AG do...

Read More
news image

AMAZON INTENSIFIES PUSH INTO AUSTRALIAN PHARMACY WITH TRADEMARK APPLICATION

Smh | June 01, 2020

Retail giant Amazon has intensified its push into Australia's highly competitive pharmaceuticals sector, brushing off industry opposition with a fresh trademark application for a range of private-label over-the-counter medications. Amazon filed the application for the 'BasicCare' trademark on Friday and refers to Amazon-branded medication which shoppers can buy directly from the e-commerce giant. The move comes as Amazon faces a fight with the Pharmacy Guild of Australia over a previ...

Read More
news image

PHARMA TECH

FRONTAGE LABORATORIES ACQUIRES ACCELERA S.R.L.'S BIOANALYTICAL AND DMPK BUSINESSES

PR Newswire | January 03, 2024

Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera). Accelera is a premier Contract Research Organization located in Nerviano, within the Lombardy region of Italy, part of the well-established NMS Group S.p.A. which has positioned itself as a global niche player in delivering discovery &...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us